KYTX
Kyverna Therapeutics Inc.
$6.52
+$0.72(+12.41%)
41
Overall
--
Value
41
Tech
--
Quality
Market Cap
$250.82M
Volume
1.01M
52W Range
$1.78 - $7.20
Target Price
$18.20
EPS Estimates Overview
| Current Quarter | $-0.94 | Next Quarter | $-0.95 |
| Current Year | $-3.86 | Next Year | $-3.67 |
| QoQ Growth | -1.1% | YoY Growth | +4.9% |
| 3Y EPS CAGR | +77.1% | Target Price | $18.20 |
| Consensus | Buy | Upside | +179.1% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KYTX | $6.52 | +12.4% | 1.01M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Kyverna Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW